Controlling type 1 diabetes could be as easy as sending a text, literally

Patients living with type 1 diabetes are constantly tinkering with glucose monitors and insulin pumps. All that Dana Lewis, a health communications professional, has to do is text her pancreas--which actually combines an insulin pump and glucose monitor and connects to her smartphone to cut the hundreds of interactions conventional type 1 diabetes requires to just six a day.

Commanding the pancreas to increase blood glucose on the day of a big speech allow for Lewis to plan her day exactly how she needs. Without the hassle of continuous checking of insulin pumps and glucose monitors, she is able to send texts to her pancreas to control her chronic condition and live a more high-quality life while monitoring her diabetes effortlessly.

“Every five minutes, the system pulls data from the pump, and says 'here's what been happening,' and it pulls data from your continuous glucose monitor, which says, 'here's what your blood sugar is, and this rig,' the physical hardware, processes the data from both devices and run it through the devices and run its through the algorithm and says, based on the trend of your blood sugar, and the newest data point, plus what's happening with insulin, plus your personal settings, your about your sensitivity to insulin, what you want to target, and things like that, and you're predicted to be X," said Lewis.

Read the full story below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.